Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used for managing acute coronary syndrome. Learn about its uses, effects, and precautions.

Aggrastat is primarily used to prevent blood clots in patients with acute coronary syndrome. This medication works by inhibiting platelet aggregation, which is crucial for maintaining blood flow in the coronary arteries. It is often administered in hospital settings for short-term use during procedures like angioplasty. What is Aggrastat used for? It is typically used for managing conditions that require immediate blood thinning to prevent clotting.

Common effects of Aggrastat may include bleeding, bruising, and low blood pressure. Some patients might experience nausea or dizziness. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

Aggrastat should be handled with care, especially in patients with a history of bleeding disorders or recent surgery. It is important to monitor blood clotting times regularly during treatment. Always follow the advice of a healthcare professional regarding the administration and monitoring of this medication.

Aggrastat may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol should be avoided as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.